Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
-1.01 %
$ 42.2 M
Market Cap
-2.2
P/E
LTRN - DEPRECIATION & AMORTIZATION
Depreciation & Amortization LTRN - Lantern Pharma Inc.
14.6 K
LAST VALUE
47.03%
2 YEAR CAGR
50.59%
5 YEAR CAGR
0.00%
10 YEAR CAGR